CYCLERION THERAPEUTICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.82 USD | -7.24% |
|
-7.24% | -15.82% |
| 05/03 | Cyclerion Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Cyclerion Therapeutics, Inc. Appoints Regina Graul as President | CI |
Chart calendar Cyclerion Therapeutics, Inc.
17264e71cb7e67832f5b0889cd.2VXTM7ROf_sgug6OPHySs2B8s2rAcn7Ugd_XPGAiMtk.qRm0ZuYqBapGz3y9fxj3nglP-CepNw-m0-mzZipYebyrPKVp5icImkTsXw~371880358b80c08cdf52ea76a92ccb26
Upcoming events on Cyclerion Therapeutics, Inc.
No events available
Past events on Cyclerion Therapeutics, Inc.
| 01/05/2024 | Q1 2024 Earnings Release (Projected) |
| 15/05/2023 05:30 pm | Annual General Meeting |
| 12/05/2023 03:30 am | Q1 2023 Earnings Release |
| 23/03/2023 02:10 am | Q4 2022 Earnings Release |
| 10/08/2022 01:30 am | Interim 2022 Earnings Release |
| 28/07/2022 05:30 pm | CY6463 MELAS Study Clinical Data Update Call |
| 28/06/2022 05:30 pm | Business Update Call |
| 17/06/2022 | International Conference |
| 14/06/2022 05:30 pm | Annual General Meeting |
| 11/06/2022 03:00 am | United Mitochondrial Disease Foundation Mitochondrial Medicine Symposium - Panel |
| 10/06/2022 06:30 am | United Mitochondrial Disease Foundation Mitochondrial Medicine Symposium |
| 05/05/2022 01:31 am | Q1 2022 Earnings Release |
| 18/11/2021 01:30 pm | Jefferies London Healthcare Conference |
| 10/11/2021 02:31 am | Q3 2021 Earnings Release |
| 01/10/2021 12:10 am | Cantor Fitzgerald Global Healthcare Conference |
| 13/09/2021 04:30 pm | H.C. Wainwright Global Investment Conference |
| 27/08/2021 12:30 am | Biomarkers for Alzheimer Disease Summit - Q&A |
| 27/08/2021 12:00 am | Biomarkers for Alzheimer Disease Summit |
| 26/08/2021 01:50 am | Biomarkers for Alzheimer Disease Summit |
| 30/07/2021 02:30 am | Interim 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,51 3,50 28.77% | 2,30 0,00 - | 3,94 4,31 -8.53% |
|
EBITDA Million USD | Released Forecast Spread | -122 -117 -4.38% | -80,6 -81,4 0.91% | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -125 -124 -1.24% | -81,3 -87,0 6.59% | -55,2 -53,7 -2.77% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -123 -122 -1.24% | -77,8 -83,0 6.26% | -51,6 -54,2 4.65% |
|
Net income Million USD | Released Forecast Spread | -123 -122 -0.83% | -77,8 -83,0 6.27% | -51,6 -54,2 4.65% |
|
EPS USD | Released Forecast Spread | -89,8 -99,0 9.27% | -51,2 -32,8 -56.1% | -26,4 -27,6 4.35% |
| Announcement Date | 12/03/20 | 25/02/21 | 24/02/22 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,53 0,90 -40.78% | 0,71 0,28 158.55% | 0,31 0,36 -13.92% | 0,00 0,15 - |
|
EBIT Million USD | Released Forecast Spread | -14,3 -13,3 -7.89% | -13,0 -15,7 17.3% | -13,4 -14,6 7.91% | -10,6 -14,8 28.29% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,8 -13,3 18.94% | -13,0 -15,7 17.34% | -13,4 -14,1 5.34% | -10,5 -14,8 28.94% |
|
Net income Million USD | Released Forecast Spread | -10,8 -13,3 18.94% | -13,0 -15,7 17.34% | -13,4 -14,1 5.34% | -10,5 -14,8 28.94% |
|
EPS USD | Released Forecast Spread | -4,72 -6,00 21.29% | -6,00 -7,20 16.67% | -6,20 -6,00 -3.33% | -4,80 -6,20 22.58% |
| Announcement Date | 24/02/22 | 04/05/22 | 09/08/22 | 03/11/22 |
More events
Past sector events for Cyclerion Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CYCN Stock
- Calendar Cyclerion Therapeutics, Inc.
